What does Nutriband Inc. do?
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA buprenorphine and AVERSA methylphenidate. It has a commercial development and…
What is Nutriband Inc.'s P/E and P/B ratio?
Nutriband Inc. has a P/E ratio of -11.0 and a P/B ratio of 13.25.
What is Nutriband Inc.'s debt-to-equity ratio?
Nutriband Inc. has a debt-to-equity ratio of 0.04.
How much does Nutriband Inc. owe compared with what it owns?
Nutriband Inc. owes $0.15 for every $1 it owns (balance sheet Jul 2026), which is low.
What is Nutriband Inc.'s Positivity rank?
Nutriband Inc. is ranked #5,639 of 6,774 companies globally and #3,106 of 4,000 in United States on PositoAI, with a Positivity Score of 16,522.
Does Nutriband Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Nutriband Inc..
Where can I read the latest news about Nutriband Inc.?
Recent headlines about Nutriband Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Nutriband Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Nutriband Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.